Results: 101 news stories
Scientists at The University of Texas at San Antonio (UT San Antonio) are investigating a major immune system pathway that leads to the development of chronic pain and a drug that has the potential to stop the process in its tracks. Their study, published April 22 in Cell Reports, is the first of its kind to show a path toward the prevention of chronic pain.
The university is aware of a global Canvas service issue currently preventing users from logging into the application. The reported issue is impacting multiple educational institutions across the nation.
Claudia Suemoto, MD, PhD, from The University of Texas at San Antonio (UT San Antonio), has been awarded a $500,000 UT System Faculty STARs (Science and Technology Acquisition and Retention) award to tackle urgent research gaps in dementia. South Texas offers a distinct blend of genetic and environmental factors rarely explored in neurodegenerative research. […]
UT San Antonio awarded $44 million NIH contract to advance landmark RURAL Cohort Study
¸£ÀûÒ»ÇøÔÚÏß researchers awarded grant to study how circadian rhythm disruptions may contribute to Alzheimer’s
Written by: Claire Kowalick More than 70% of cancers — including breast, bladder, cervical and lung cancer — show evidence of mutations linked to a group of enzymes called apolipoprotein B mRNA-editing enzyme catalytic polypeptides, or APOBEC. “APOBEC mutagenesis is the second-largest source of mutation in cancer and, importantly, the largest one we can do […]
The University of Texas at San Antonio was recently awarded a highly competitive Alzheimer’s Association research grant to investigate the gene-environment interaction and how it may contribute to an increased risk for Alzheimer’s disease. The grant will begin in April and provides $200,000 to fund the study over the next three years.
Rehabilitation Research Day combines research with lived experience
The Joe R. and Teresa Lozano Long School of Medicine at UT San Antonio, in collaboration with the Be Well Institute on Substance Use and Related Disorders and its statewide program Naloxone Texas, has installed a free naloxone vending machine to expand access to lifesaving opioid overdose reversal medication. Naloxone, commonly known by the […]
Lixin Song of UT San Antonio’s School of Nursing is inducted into Sigma’s International Nurse Researcher Hall of Fame for her global impact in cancer and caregiving research.
For more than 20 years, Lixin Song, PhD, RN, FAAN, vice dean for research and scholarship and professor of nursing at The University of Texas at San Antonio (UT San Antonio) School of Nursing, has studied how cancer patients and their families navigate the challenging experience of making decisions about treatment while facing uncertainty, […]
The BioFest Days brought the community together April 7, for an evening of discovery and connection at the ¸£ÀûÒ»ÇøÔÚÏß Center for Brain Health. Hosted as part of the 12-day, citywide celebration of biomedical advancement organized by BioMed SA, the event invited attendees to explore how research, clinical care and community involvement […]
New UT San Antonio study introduces analytical tool to better hone aging interventions When scientists test potential life‑extending interventions, often the central question simply asks if the intervention works. New research from The University of Texas at San Antonio (UT San Antonio) suggests that the more meaningful questions may be when does it work […]
¸£ÀûÒ»ÇøÔÚÏß researchers report breakthrough findings significantly reducing symptoms for combat PTSD victims
The San Antonio Breast Cancer Symposium drew more than 11,000 attendees to downtown San Antonio and generated nearly $40 million in economic impact, according to a new report from Visit San Antonio.
¸£ÀûÒ»ÇøÔÚÏß Multispecialty and Research Hospital has enrolled and treated its first clinical trial participant in a novel cancer study, marking a pivotal moment for science and patient-centered cancer care in San Antonio and South Texas.
A drug once known almost exclusively for preventing organ transplant rejection is now at the center of a National Institute on Aging-funded clinical study at ¸£ÀûÒ»ÇøÔÚÏß, to determine how rapamycin should be used in older adults to promote healthy aging.
The University of Texas at San Antonio (UT San Antonio) School of Dentistry is ranked ninth nationally and first in Texas among all dental schools in the United States, according to the 2025 Blue Ridge Institute for Medical Research rankings. Based on National Institutes of Health (NIH) funding, the rankings are widely considered one of the most objective measures of biomedical […]
In its first appearance in the national standings as a united institution, UT San Antonio posted a strong performance in the latest rankings from the Blue Ridge Institute for Medical Research. The Blue Ridge Institute is an independent nonprofit organization that compiles annual funding data from the National Institutes of Health.
The Sam and Ann Barshop Institute for Longevity and Aging Studies at ¸£ÀûÒ»ÇøÔÚÏß, will receive up to $38 million to lead a national clinical trial funded by the Advanced Research Projects Agency for Health (ARPA-H), an agency of the U.S. Department of Health and Human Services.